Non-ST-elevation acute coronary syndrome: Fuel for the invasive strategy

Lancet

Volumn 360, Issue 9335, 2002, Pages 738-739

  Wallentin, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR RISK; CLINICAL TRIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; META ANALYSIS; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037036973     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09945-2     Document Type: Note

References (10)

1. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive versus non-invasive treatment in unstable coronary-artery disease. Lancet 1999; 354: 708-15.
2. Wallentin L., Lagerqvist B., Husted S., Kontny F., Ståhle E., Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet. 356:2000;9-16.
3. Lagerqvist B, Husted S, Kontny F, et al. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease - 2 year follow-up of the FRISC II invasive study. J Am Coll Cardiol (in press).
4. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887.
5. Diderholm E., Andrén B., et al. The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease. Am Heart J. 143:2002;760-767.
6. Morrow D.A., Cannon C.P., Rifai N., et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. JAMA. 286:2001;2405-2412.
7. Lagerqvist B., Safstrom K., Stahle E., et al. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? J Am Coll Cardiol. 38:2001;41-48.
8. Stenestrand U., Wallentin L. Influence of early revascularisation on 1-year survival in 14-day survivors of acute myocardial infarction - experiences from a large prospective cohort. Lancet. 359:2002;1805-1811.
9. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Eur Heart J 2000; 21: 1406-32 (updated, in press).
10. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-elevation myocardial infarction. American College of Cardiology, 2002. http://www.acc.org/clinical/guidelines/unstable/update_index.htm (accessed Sept 1, 2002).